Phuong Khanh Morrow

Insider Reports History

Location
C/O Crispr Therapeutics, 610 Main Street, Cambridge, MA
Signature
/s/ Eric M. Green, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phuong Khanh Morrow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lantheus Holdings, Inc. Director Common Stock 3.1K $321K $103.64 May 14, 2025 Direct
CRISPR Therapeutics AG Chief Medical Officer Common Shares 4.41K $276K $62.50 May 24, 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Restricted Stock Units 20.8K May 23, 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Stock Option (Right to Buy) 16.7K Oct 13, 2023 Direct
Lantheus Holdings, Inc. Director Stock Option (right to buy) 4.54K May 14, 2025 Direct

Insider Reports Filed by Phuong Khanh Morrow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LNTH Lantheus Holdings, Inc. May 14, 2025 2 $0 4 May 16, 2025 Director
LNTH Lantheus Holdings, Inc. Feb 7, 2025 1 $0 4/A Feb 12, 2025 Director
LNTH Lantheus Holdings, Inc. Feb 1, 2025 0 $0 3 Feb 7, 2025 Director
CRSP CRISPR Therapeutics AG Oct 13, 2023 1 $0 4 Oct 17, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2023 3 -$167K 4 May 25, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG Mar 10, 2023 2 $0 4 Mar 14, 2023 Chief Medical Officer
CRSP CRISPR Therapeutics AG Oct 7, 2022 1 $0 4 Oct 12, 2022 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2022 2 $0 4 May 24, 2022 Chief Medical Officer
CRSP CRISPR Therapeutics AG May 23, 2022 0 $0 3 May 23, 2022 Chief Medical Officer